Orakl Oncology

Orakl Oncology is a techbio startup and precision oncology company that combines cutting-edge biology and AI to accelerate cancer drug discovery and development. Utilizing an innovative predictive engine and one of the world's largest collections of patient tumor avatars, the company aims to de-risk clinical trials, identify new drug targets, and expand the therapeutic arsenal available to cancer patients.